Category: Medmonitor

83 posts found

Medmonitor

FDA Approves New Acetaminophen Injection Dose

A new 500mg injection will soon be available.

Medmonitor

FDA Approves Posimir for Post-Surgical Pain Relief

A novel bupivacaine formulation works as a 72-hour local anesthetic following shoulder surgery.

Medmonitor

COVID-19 Mutations Impact Testing

False negatives may be reported due to genetic variations of the virus.

Medmonitor

FDA Authorizes Two COVID-19 Vaccines, At-Home Test, More Treatments

Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.

Medmonitor

FDA Approves Veklury for COVID-19, Issues EUA for Bamlanivimab

Veklury is approved for hospitalized patients, while bamlanivimab is being investigated in mild-to-moderate cases of COVID-19.

Medmonitor

FDA Requires Boxed Warning Update for Benzodiazepines

Even at recommended doses, benzodiazepine use can lead to misuse, abuse, and addiction.

Medmonitor

FDA Approves Two New Opioids

Olinvyk injections and Qdolo oral solution are approved for the management of acute pain.

Medmonitor

FDA Issues Naloxone Recommendations for Opioids and OUD Drugs

The FDA recommends healthcare professionals co-prescribe the opioid overdose reversal drug with all opioid prescriptions.

Medmonitor

FDA Approves Hulio for Rheumatoid Arthritis and More

Subcutaneous injections of the new biologic, adalimumab-fkjp, were approved for seven indications.

Medmonitor

FDA Approves Elyxyb Oral Solution for Migraines

Elyxyb (celecoxib) is an NSAID for the acute treatment of migraine with or without aura.

Medmonitor

COVID-19 Updates from the FDA

New developments with diagnostic testing and the use of chloroquine and hydroxychloroquine.

Medmonitor

FDA Approves Two Migraine Drugs and Two NSAIDs

Anjeso and a new Advil formulation target pain, while Nurtec™ and Vyepti™ target migraines.

Medmonitor

FDA Approves Diazepam Nasal Spray and Fast Tracks New Drug for Spinal Cord Injury

A new seizure drug has been approved, and a nerve growth drug advances in clinical trials.

Medmonitor

Three Drug Approvals and a Safety Warning

Migraine, arthritis, and insomnia drug approvals, and a gabapentinoids safety warning.

Medmonitor

New Drug Developments Impacting Comp

A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.

Prev 1 2 3 4 5 6 Next